Drug Shortage Report for MYLAN-TADALAFIL
Report ID | 152654 |
Drug Identification Number | 02410664 |
Brand name | MYLAN-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 BL |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2022-05-03 |
Actual start date | 2022-05-03 |
Estimated end date | 2022-07-12 |
Actual end date | 2022-07-11 |
Shortage status | Resolved |
Updated date | 2022-07-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-01-13 | English | Compare |